Is Mounjaro covered by Medicaid?
The Checkup by Singlecare
APRIL 17, 2024
Mounjaro (tirzepatide) is an injectable medication prescribed for Type 2 diabetes mellitus, which some doctors may prescribe off-label for weight loss. In 2022—the year Mounjaro hit the market—Medicaid dispersed nearly $30 million to help beneficiaries pay for it, according to KFF data. per 30-day supply (a pack of four pens).
Let's personalize your content